medical affairs outsourcing, pharma market solutions, pharmaceutical services and consulting, pharmaceutical validation, pharma supply chain management, marketing of pharmaceutical products, regulatory affairs pharmaceutical, preclinical research companies, pharma marketing solutions, global pharmaceutical company, aseptic filling process in pharma, biomarker analysis in clinical trials, biotech companies, patent and intellectual property, chemistry manufacturing and controls training, cleaning validation, cleaning verification in pharmaceutical industry, regulatory affairs cmc, clinical data management, clinical research organisations London, clinical research management system, clinical trial companies, clinical trials in the uk, consultancy pharmaceutical industry, consultant for pharmaceutical industry, consultant pharmaceutical, consultant regulatory affairs, consulting services pharmaceutical industry, continuous manufacturing in pharma, contract research organisations uk,

Intellectual Property Services

The defining characteristic of the international research-based pharmaceutical industry is its commitment to innovative, but expensive, R&D investment, and the cornerstone of protecting this investment is via executing a robust intellectual property (IP) policy.

At TBS we understand the importance of IP policy and how it relates to ensuring that an asset is protected, compliant and fulfills its maximum Return on Investment (RoI). Whether you are an innovator seeking protection for a New Chemical Entity (NCE) or a generic/biosimilar manufacturer, we can help create a clear road map to launch your products.

IP Portfolio Management & Optimization

Value maximization: IP management of existing portfolios, including supporting R&D teams to identify evergreening or repurposing/reprofiling of current and future pipelines. i.e., 505b(2) products, i.e., new formulations, routes of delivery, chemical modifications (salts) and enantiomer switches.

  • Expertise with both small and large molecule products as well as MedTech, Diagnostic products

  • Review and clarifications for in-house teams when it comes to parallel “sui generis” rights in the pharmaceutical industry, i.e., data protection, market protection, Supplementary Protection Certificate (SPC) and Orphan designation

  • In conjunction with other commercial services input into due diligence and gap analysis activities to provide a “complete picture.”

  • Providing go/no decisions for New Product Development (NPD) teams when looking to develop pharmaceutical assets

2

Patent Drafting & Intelligence

  • Conducting Freedom to Operate (FTO) searches for in/out licensing deals

  • Patentability evaluations that highlight patent infringement

  • Patent searches

  • Patent analytics services for the fund raising community (VC/PE/Angel/Hedge Fund), i.e., helping investors understand the current/future life science IP landscape to identify "hot" areas in the healthcare space

  • Developing patentability arguments for/against

regulatory in pharmaceutical industry, regulatory pharma, regulatory strategy medical device, scientific consulting, scientific consulting companies, scientific consulting firms, small cros, solution in pharmaceutics, solutions pharma, sterile medicinal products, technology pharmaceutical, the global consulting organization, the global pharmaceutical industry, the it consultancy group, the medical company, the patent attorneys, the pharma industry, toxicology models, trials medical, us pharma, us pharma companies, us pharma industry, us pharma market, us pharma products, us pharmaceutical, us pharmaceutical companies, us pharmaceutical industry, us pharmaceutical market, us pharmaceutical production, us pharmaceuticals, validation consultancy, validation consultants, validation of cleaning processes, verification of analytical methods, world consulting, world group consulting, medical affairs outsourcing, pharma market solutions, pharmaceutical services and consulting

Let's Work Together